Pharmaceutical News

Pharmaceutical News & Media

Valeant Pharmaceuticals International, Inc. (NYSE: VRX/TSX: VRX) completed its acquisition of Salix Pharmaceuticals, Ltd. ("Salix") on April 1, 2015.

Read the latest Investor Relations information from Valeant

SWB11-0814




Explore Career Opportunities with Salix